Search Results
Results found for "mu opioid receptor"
- Dylan Eiger | Dr. GPCR Ecosystem
focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Flash Presentations Health and Disease, Metabolism, Nervous System, Proteomics and Transcriptomics, Receptor Adhesion GPCR Signaling In Vivo Lara-Sophie Brodmerkel Novel isoforms of adhesion G protein coupled receptor Recent studies implicate the dysregulation of adhesion G-Protein coupled receptors (GPCRs) in GBM development However, the physiological relevance of flap flexibility on receptor activation and signaling remains The cleaved BAI1 isoform has a 19 amino acid extracellular stalk that can serve as a receptor agonist
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors His doctoral research focused on the structural and functional characterization of bitter taste receptors
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors
- From aspiring doctor to GPCR scientist! 🔬In this episode, Ian Chronis shares his journey from med school dreams to a PhD in pharmacology, diving into the fascinating world of receptor signaling. Can you guess what’s his favorite GPCR? ✅ Hear his response: Ep 164 with Dr. Ian Chronis #SciencePodcast #GPCR #PhDLife #DrGPCR | Dr. GPCR Ecosystem
shares his journey from med school dreams to a PhD in pharmacology, diving into the fascinating world of receptor shares his journey from med school dreams to a PhD in pharmacology, diving into the fascinating world of receptor
- Forget one receptor at a time. Go big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing, miniaturization, and collaboration. The tools are built. The data is free. What will you ask next? 📲 Dive in: Ep 167 with Drs. Tom Sakmar & Ilana Kotliar #GPCRtraining #GPCRresearchcommunity #DrGPCR #GPCRdata | Dr. GPCR Ecosystem
Home → Flash News → Forget one receptor at a time. GPCR Podcast Forget one receptor at a time.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
Aurelien Rizk shared that he had always focused on GPCRs but had also worked on other types of receptors Yamina Berchiche had a detailed conversation about the intricacies of cell signaling and chemokine receptors They validated their technology and made collaborations for expertise on chemokine receptors. Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about They emphasized the need to quantify the dynamics of the pathways and the residence time of the receptor
- Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
approaches to quantify ligand bias and the identification of ACKR3 as an endogenously beta-arrestin-biased receptor His group and others have shown that many of these ligands act as biased agonists for the same receptor
- New cryo-EM insights reveal how extracellular domains communicate with transmembrane regions in holo-adhesion GPCRs, uncovering mechanisms behind receptor activation. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/adhesion-gpcrs/conformational-coupling-between-extracellular-and-transmembrane-domains-modulates-holo-adhesion-gpcr-function #gpcr #drgpcr | Dr. GPCR Ecosystem
domains communicate with transmembrane regions in holo-adhesion GPCRs, uncovering mechanisms behind receptor domains communicate with transmembrane regions in holo-adhesion GPCRs, uncovering mechanisms behind receptor
- Did you know? 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! 🧬💡 These innovative compounds, “Photo-BQCisA” and “Photo-BQCtrAns,” offer subtype-selective precision by combining allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors (M1-M5). 🔬✨ Learn more about this breakthrough in the Ecosystem! | Dr. GPCR Ecosystem
allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
also went on to discover a “counterion switch” in visual pigments and to develop strategies to assay receptor-G-protein from this work, such as the concept of “functional micro-domains” and the “helix movement model of receptor , the parallel development of bioorthogonal labeling strategies to couple fluorophores to expressed receptors
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
and received my Ph.D. in Molecular Medicine in 2010 after studying the orphan atypical cannabinoid receptor I studied the function of RGS5, calcium-sensing receptor, and an orphan adhesion GPCR, GPR64/ADGRG2 in
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide for quantitative, and multi‐scale integration of these amounts of data to gain novel insights into receptor
- Dr. Raul Gainetdinov | Dr. GPCR Ecosystem
Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification
- Did you know that GPR20, a potential therapeutic target to treat gastrointestinal stromal tumours, performs high constitutive activity when coupling with Gi? Check out this paper to see how molecular dynamics simulation can be used to explore its constitutive activation mechanism. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/exploring-the-constitutive-activation-mechanism-of-the-class-a-orphan-gpr20 #gpcr #drgpcr | Dr. GPCR Ecosystem
➡️https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/exploring-the-constitutive-activation-mechanism-of-the-class-a-orphan-gpr20 ➡️ https:// www.ecosystem.drgpcr.com/receptor-activation-and-signaling/exploring-the-constitutive-activation-mechanism-of-the-class-a-orphan-gpr20
- Dr. Timo De Groof | Dr. GPCR Ecosystem
within the research group and used this platform to develop nanobodies targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine receptor US28.
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular
- Genetic Deletion of Atypical VGLUT3 Rescues Huntington’s Disease Phenotype and Neurodegeneration in zQ175 Mice
/ 2:10 PM About Karim Ibrahim "A postdoctoral researcher, interested in studying G-protein coupled receptors
- "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways
With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular
- We’re excited to announce our strategic partnership with Celtarys Research, a biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive GPCR assays. This collaboration combines Dr. GPCR’s global platform with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery. We’re proud to welcome Celtarys to the Dr. GPCR ecosystem to support researchers worldwide and expand access to high-performance tools for GPCR-targeted therapeutics. ✳️Read the complete press release: https://www.ecosystem.drgpcr.com/post/dr-gpcr-and-celtarys-research-join-forces-to-expand-access-to-innovative-gpcr-tools #GPCR #DrGPCR #CeltarysResearch #DrugDiscoveryTools #FluorescentLigands #GPCRresearch #ScientificPartnership | Dr. GPCR Ecosystem
Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor Celtarys’ innovative chemical biology tools , making it easier than ever for scientists to study ligand-receptor
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
Sponsors GPCR Retreat Program < Back to schedule Pharmacological and Genetic Preclinical Models of Ghrelin Receptor
- encoding and decoding selectivity and promiscuity in the human chemokine GPCR interaction network | Dr. GPCR Ecosystem
The result: a framework for designing ligands with altered receptor preferences. ♦️ Defines “public”
- Dr. GPCR Board | Dr. GPCR Ecosystem
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
Uppsala University is redefining GPCR drug discovery with predictive molecular modeling that forecasts receptor Their lab doesn’t just simulate receptor-ligand interactions after the fact; they aim to forecast receptor
- How do GRK-specific phosphorylation barcodes influence β-arrestin binding to GPCRs? New cryo-EM structures from Chen et al. (Nature, 2025) reveal that β-arrestin1 and β-arrestin2 form distinct complexes with ACKR3 depending on whether it's phosphorylated by GRK2 or GRK5, shaping arrestin conformation, complex stability, and engagement mode. Surprisingly, arrestin’s finger loop didn’t dive into the receptor core. Instead, it latched onto the micelle surface, breaking canonical expectations. Also, β-arrestin2 lacks a membrane anchor, making it more dynamic — a potential clue to its functional specialization. These findings underscore how barcode location + arrestin isoform = unique signaling outcomes. open book Read the full study: Inside Out: Mapping GPCRs from Membrane Codes to Market Moves #GPCRs #Arrestin #ACKR3 #GRKs #CryoEM #StructuralBiology #SignalingBias #Phosphorylation #DrGPCR | Dr. GPCR Ecosystem
Surprisingly, arrestin’s finger loop didn’t dive into the receptor core. Surprisingly, arrestin’s finger loop didn’t dive into the receptor core.
- insights into g protein coupling preference from cryo em structures of gq bound PTH1R | Dr. GPCR Ecosystem
cryo-EM structures of Gq-bound PTH1R—highlighting how N-linked glycans and ICL2 interactions stabilize receptor
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity Adam A2B adenosine receptor-triggered intracellular calcium mobilization: Cell type-dependent involvement selectivity Ligand-Independent Spontaneous Activation of Purinergic P2Y6 Receptor Under Cell Culture Soft Substrate 🔎 GPCR KEYWORDS Class-A G protein-coupled receptors , Lophotrochozoa , echinoderms , nerve injury , neuropathic pain , spinal cord dorsal horn , OPN3 , cAMP signalin g , MC4R , docking , opioid
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled receptors At Medarex, she initiated and identified the lead mAb for the type I interferon-alpha receptor project



















